Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
5.96
-0.09 (-1.49%)
Jul 20, 2026, 9:58 AM EDT - Market open
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $664.47 million as of July 20, 2026. Its market cap has increased by 1.66% in one year.
Market Cap
664.47M
Enterprise Value
625.52M
1-Year Change
1.66%
Ranking
Category
Stock Price
$5.96
ChartMarket Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $664.47M, an increase of 28.92%. That is a compound annual growth rate of 9.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 664.47M | 3.55% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 729.70M |
| Climb Bio | 727.21M |
| Omeros | 701.32M |
| ARS Pharmaceuticals | 695.12M |
| SL Science Holding | 694.99M |
| BridgeBio Oncology Therapeutics | 685.72M |
| Faeth Therapeutics | 666.90M |
| SpyGlass Pharma | 660.98M |